Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by RNA, Technology and IP AttorneysWhat should Indian business owners do to protect their trade secrets? Rachna Bakhru of RNA Technology and IP Attorneys provides a guide by piecing together the various applicable statutes and principles -
Sponsored by Maiwald Intellectual PropertyOwners of German trademarks who rely on their use in Switzerland to protect their mark must change their strategy immediately, as Susanna Heurung of Maiwald explains
-
Sponsored by AJ ParkAJ Park considers the implications of the New Zealand – EU free trade agreement for wine, cheese, and Mānuka honey
-
Sponsored by Tilleke & GibbinsLinh Thi Mai Nguyen and Chi Lan Dang of Tilleke & Gibbins outline the IP changes that will come into force in 2023, and share their opinion on the merits and drawbacks of each
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law summarises the key points of the Korean Intellectual Property Office’s updated guidance regarding artificial intelligence patent filings as the intellectual property world adapts to a growing area
-
Sponsored by FB RiceJacqueline Warner and Marcus Caulfield of FB Rice explain the significance of common general knowledge (CGK) in the patentability of inventions in Australia and the evidentiary processes that are adopted as a result
